Journal
MEDICAL MOLECULAR MORPHOLOGY
Volume 54, Issue 2, Pages 187-191Publisher
SPRINGER JAPAN KK
DOI: 10.1007/s00795-020-00269-z
Keywords
Metanephric adenoma; BRAF V600K; BRAF VE1 antibody
Categories
Funding
- Universita Cattolica del Sacro Cuore within the CRUI-CARE Agreement
Ask authors/readers for more resources
Metanephric adenoma (MA) is a rare benign renal tumor that can be challenging to diagnose, and sequencing analysis may be necessary for cases of MA with negativity for BRAF VE1 clone.
Metanephric adenoma (MA) is an uncommon benign renal tumor whose histomorphological aspect resembles that of Wilms' tumor and papillary renal cell carcinoma. From a diagnostic and therapeutic perspective, recognition of this entity is important as it has a more favorable clinical outcome compared with Wilms' tumor and papillary renal cell carcinoma. MA should not be treated with nephrectomy if the tumor size is small, opting for a conservative treatment. However, the preoperative diagnosis of this disease is extremely challenging. The present study describes a case of this rare disease, showing an ambiguous radiological imaging and that only after a percutaneous biopsy, was defined as a MA and treated with partial nephrectomy. Moreover, the histological diagnosis of this case was partially complicated by the equivocal immunohistochemical analysis showing negativity for BRAF VE1 staining. Only the mutational analysis demonstrated the presence of the BRAF V600K mutation (for the first time described in a case of metanephric adenoma), highlighting the necessity of sequencing in case of MA with negativity for BRAF VE1 clone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available